» Articles » PMID: 35642835

Elucidating a Bidirectional Association Between Rheumatoid Arthritis and Depression: A Systematic Review and Meta-analysis

Overview
Journal J Affect Disord
Date 2022 Jun 1
PMID 35642835
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Rheumatoid arthritis (RA) and depression are conditions which commonly co-exist. Recent longitudinal studies now suggest a bidirectional association between these disorders, with inconsistent results. We conducted a systematic review and meta-analysis to examine this relationship.

Methods: Three electronic databases (PubMed, Embase and PsycINFO) were searched from inception to September 4, 2021 for cohort studies evaluating either the risk of depression in RA patients or the risk of RA in patients with depression, as well as the secondary outcome of all-cause mortality risk in RA patients with depression. A random effects model was used to summarize the included studies.

Results: Eleven cohort studies were included, comprising a total of 39,130 RA patients, 550,782 patients with depression and 7,802,230 controls. RA patients had a 47% greater risk of incident depression compared to controls, while patients with depression had a 34% greater risk of developing RA. Subgroup analysis by age was only significant in the ≥60 years old age group. RA patients with depression had an 80% increased risk of all-cause mortality compared to those without depression.

Limitations: The results may have been confounded by factors such as differing methods of depression ascertainment across studies and overlap in presentation between the two conditions.

Conclusion: There exists a bidirectional association between RA and depression especially in the elderly which increases mortality risk. This invites the need for clinicians to screen and be vigilant for the presence of these conditions.

Citing Articles

Health-related quality of life profiles in patients with rheumatoid arthritis: a latent profile analysis.

Song Y, Chen Y, Wen L, He B, Ding Y, Liu M Front Public Health. 2025; 12:1478376.

PMID: 39744379 PMC: 11688321. DOI: 10.3389/fpubh.2024.1478376.


Association of improvement and worsening of depressive symptoms with arthritis.

Liu R, Xin Y, Shao Y, Wu B, Liu Y BMC Geriatr. 2024; 24(1):909.

PMID: 39501170 PMC: 11536955. DOI: 10.1186/s12877-024-05498-w.


Implementing Patient Health Questionnaire Depression Screening in Inflammatory Arthritis Clinic: Insights From a Quality Improvement Project at a Tertiary Rheumatology Center.

Yu J, Goodman S, Rakowicz A, Bugante J, Lee J ACR Open Rheumatol. 2024; 7(1):e11764.

PMID: 39479771 PMC: 11694136. DOI: 10.1002/acr2.11764.


Trends in Anxiety and Depression Among Individuals With Rheumatoid Arthritis: A Population-Based Study.

Giblon R, Achenbach S, Myasoedova E, Davis 3rd J, Kronzer V, Bobo W J Rheumatol. 2024; 52(3):210-218.

PMID: 39406405 PMC: 11882373. DOI: 10.3899/jrheum.2024-0165.


Tocilizumab Reduces Depression Risk in Rheumatoid Arthritis Patients: A Systematic Review and Meta-Analysis.

Baghdadi L Psychol Res Behav Manag. 2024; 17:3419-3441.

PMID: 39381332 PMC: 11460349. DOI: 10.2147/PRBM.S482409.